tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Technical Analysis

Compare
554 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Neurogene’s (NGNE) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Neurogene is a Buy.
Neurogene’s (NGNE) 20-Day exponential moving average is 18.29, while Neurogene’s (NGNE) share price is $16.57, making it a Sell.
Neurogene’s (NGNE) 50-Day exponential moving average is 17.53, while Neurogene’s (NGNE) share price is $16.57, making it a Sell.

Neurogene (NGNE) Pivot Points

Jun 28, 2025, 12:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.51
16.01
16.44
16.94
17.38
17.88
18.31
Fibonacci
16.01
16.37
16.59
16.94
17.30
17.52
17.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurogene (NGNE) Moving Averages

Jun 28, 2025, 12:50 PM
Period
Simple
Exponential
MA5
17.13Sell
17.20Sell
MA10
18.15Sell
17.92Sell
MA20
19.22Sell
18.29Sell
MA50
16.96Sell
17.53Sell
MA100
16.22Buy
18.31Sell
MA200
25.06Sell
25.24Sell
Neurogene’s (NGNE) 10-Day exponential moving average is 17.92, while Neurogene’s (NGNE) share price is $16.57, making it a Sell.
Neurogene’s (NGNE) 100-Day exponential moving average is 18.31, while Neurogene’s (NGNE) share price is $16.57, making it a Sell.
Neurogene’s (NGNE) stock price is $16.57 and Neurogene’s (NGNE) 50-day simple moving average is 16.96, creating a Sell signal.
Neurogene’s (NGNE) stock price is $16.57 and Neurogene’s (NGNE) 100-day simple moving average is 16.22, creating a Buy signal.
Neurogene’s (NGNE) stock price is $16.57 and Neurogene’s (NGNE) 200-day simple moving average is 25.06, creating a Sell signal.

Neurogene (NGNE) Technical Indicators

Jun 28, 2025, 12:50 PM
Name
Value
Implied Action
RSI (14)
42.57
Neutral
STOCH (9,6)
8.09
Buy
STOCHRSI (14)
4.94
Buy
MACD (12,26)
-0.09
Buy
ADX (14)
24.32
Neutral
Williams %R
-96.96
Buy
CCI (14)
-112.55
Buy
ATR (14)
1.80
-
Ultimate Oscillator
24.40
Sell
ROC
-27.71
Sell
Neurogene’s (NGNE) Relative Strength Index (RSI) is 42.57, creating a Neutral signal.
Neurogene’s (NGNE) Trend Strength Indicator (ADX) is 24.32, creating a Neutral signal.
Neurogene’s (NGNE) Commodity Channel Index (CCI) is -112.55, creating a Buy signal.
Neurogene’s (NGNE) Price Rate of Change (ROC) is -27.71, creating a Sell signal.

FAQ

Is NGNE a Buy, Hold, or Sell?
Based on NGNE’s technical indicators, NGNE is a Sell.
    What is NGNE’s RSI (14)?
    NGNE’s RSI (14) is 42.57, which suggests NGNE is a Neutral.
      What is NGNE’s MACD?
      NGNE’s MACD is -0.09, which suggests NGNE is a Buy.
        What is NGNE’s 5-day moving average?
        NGNE’s 5-day moving average is 17.13, which suggests NGNE is a Sell.
          What is NGNE’s 20-day moving average?
          NGNE 20-day moving average is 19.22, which suggests NGNE is a Sell.
            What is NGNE’s 50-day moving average?
            NGNE’s 50-day moving average is 16.96, which suggests NGNE is a Sell.
              What is NGNE’s 200-day moving average?
              NGNE’s 200-day moving average is 25.06, which suggests NGNE is a Sell.
                What is NGNE’s Williams % R (14)?
                NGNE’s Williams % R (14) is -96.96, which suggests NGNE is a Buy.
                  What is NGNE’s CCI (14)?
                  NGNE’s CCI (14) is -112.55, which suggests NGNE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis